Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies - Concepedia

Concepedia

Publication | Open Access

Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies

DOI Full Paper Access

40

Citations

25

References

2016

Year

Hanna Savolainen‐Peltonen, Pauliina Tuomikoski, Pasi Korhonen, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala, Tomi S. Mikkola

The Journal of Clinical Endocrinology & Metabolism

Abstract

Estradiol-based hormone therapies are accompanied with larger CHD mortality risk reductions the earlier the therapies are initiated. The progestin component of EPT does not modify this "timing effect."

References

	Year	Citations

Page 1